Zivo Bioscience Reports Director, Officer, and Compensation Changes

Ticker: ZIVOW · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1101026

Zivo Bioscience, Inc. 8-K Filing Summary
FieldDetail
CompanyZivo Bioscience, Inc. (ZIVOW)
Form Type8-K
Filed DateAug 18, 2025
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: management-change, officer-appointment, director-election, compensation

Related Tickers: ZIVO

TL;DR

Zivo Bioscience (ZIVO) filed an 8-K detailing changes in directors, officers, and compensation arrangements.

AI Summary

Zivo Bioscience, Inc. filed an 8-K on August 18, 2025, reporting events as of August 12, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding these changes and arrangements are outlined within the report.

Why It Matters

Changes in a company's board of directors and executive officers, along with details on their compensation, can signal shifts in strategy, governance, or financial priorities.

Risk Assessment

Risk Level: medium — Changes in key personnel and compensation can indicate internal shifts that may impact future performance or strategy.

Key Players & Entities

  • Zivo Bioscience, Inc. (company) — Registrant
  • August 12, 2025 (date) — Earliest event reported
  • August 18, 2025 (date) — Date of report

FAQ

What specific changes occurred regarding directors or officers?

The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is dated August 12, 2025.

What type of compensatory arrangements are mentioned?

The filing mentions compensatory arrangements of certain officers.

What is the state of incorporation for Zivo Bioscience, Inc.?

Zivo Bioscience, Inc. is incorporated in Nevada.

What is the SIC code for Zivo Bioscience, Inc.?

The Standard Industrial Classification (SIC) code for Zivo Bioscience, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-08-18 16:12:34

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to p

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ Keith Marchiando Keith Marchiando Chief Financial Officer Date: August 18, 2025 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.